Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Tigan (Trimethobenzamide Hydrochloride) Suppositories, Injection, King NDA 17-529/S-009, 17-530/S-018 4/30/02 5/2/02 5/24/02 Tigan (Trimethobenzamide Hydrochloride) Capsules, King NDA 17-531/S-010 4/30/02 1/13/03 1/13/03 Tigan (Trimethobenzamide Hydrochloride) Capsules, 300 mg, King NDA 17-531 Trimethobenzamide Hydrochloride Capsules, 300mg Mutual Pharmaceutical ANDA 76-570 8/28/03 Trimethobenzamide Hydrochloride Capsules, 300mg Amide ANDA 76-546 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TRIMETHOBENZAMIDE HCL Amide 017531 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TIGAN KING 076570 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TRIMETHOBENZAMIDE HCL Mutual 088804 TRIMETHOBENZAMIDE HYDROCHLORIDE Injection 100MG/ML TRIMETHOBENZAMIDE HCL Abbott 017530 TRIMETHOBENZAMIDE HYDROCHLORIDE Injection 100MG/ML TIGAN KING | Tigan (trimethobenzamide hydrochloride) Injection, King Pharma, Formulation Revision, Package Change & Manufacturing Change or Addition | Tigan (trimethobenzamide hydrochloride) Capsules, King Pharma, Labeling Revision | Tigan (trimethobenzamide hydrochloride) Intramuscular Injection, JHP Pharma, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com